Company intelligence / Profile preview

Solaga

Berlin, Berlin, Germanybook.solaga.co.uk ↗

Ownership: Private
Development stage: Commercial

Overview

Solaga has developed proprietary microalgae biofilm systems that absorb harmful airborne pollutants such as nitrogen oxides and fine dust. Their decorative "algae pictures" are commercially available for improving indoor air quality. Larger-scale solutions like urban algae filters and biogas production from algae are under development. The company has received several innovation awards but does not conduct clinical trials as it does not develop drugs or medical devices.

Modalities: Microbial therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Solaga.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solaga.

Explore the full profile